658 related articles for article (PubMed ID: 26712222)
1. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
[TBL] [Abstract][Full Text] [Related]
3. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
4. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
Lewis JS; Thorstad WL; Chernock RD; Haughey BH; Yip JH; Zhang Q; El-Mofty SK
Am J Surg Pathol; 2010 Aug; 34(8):1088-96. PubMed ID: 20588174
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
6. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
7. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
10. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
Vermorken JB; Psyrri A; Mesía R; Peyrade F; Beier F; de Blas B; Celik I; Licitra L
Ann Oncol; 2014 Apr; 25(4):801-807. PubMed ID: 24577117
[TBL] [Abstract][Full Text] [Related]
12. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
[TBL] [Abstract][Full Text] [Related]
13. Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.
Pajares B; Trigo JM; Toledo MD; Álvarez M; González-Hermoso C; Rueda A; Medina JA; de Luque V; Jerez JM; Alba E
BMC Cancer; 2013 Jan; 13():26. PubMed ID: 23331666
[TBL] [Abstract][Full Text] [Related]
14. Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases.
Pitiyage G; Lei M; Guererro Urbano T; Odell E; Thavaraj S
Diagn Pathol; 2015 Jul; 10():97. PubMed ID: 26169909
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.
Fakhry C; Zhang Q; Nguyen-Tan PF; Rosenthal D; El-Naggar A; Garden AS; Soulieres D; Trotti A; Avizonis V; Ridge JA; Harris J; Le QT; Gillison M
J Clin Oncol; 2014 Oct; 32(30):3365-73. PubMed ID: 24958820
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.
Riaz N; Sherman E; Koutcher L; Shapiro L; Katabi N; Zhang Z; Shi W; Fury M; Wong R; Wolden S; Rao S; Lee N
Am J Clin Oncol; 2016 Feb; 39(1):27-31. PubMed ID: 24401670
[TBL] [Abstract][Full Text] [Related]
17. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
Lassen P; Primdahl H; Johansen J; Kristensen CA; Andersen E; Andersen LJ; Evensen JF; Eriksen JG; Overgaard J;
Radiother Oncol; 2014 Dec; 113(3):310-6. PubMed ID: 25544647
[TBL] [Abstract][Full Text] [Related]
18. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
[TBL] [Abstract][Full Text] [Related]
19. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
20. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
